Quick Answer
Pulmonx Corp reported Operating Income of -$53.66 million for fiscal year 2025.
Pulmonx Corp Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$53.66M | +7.0% |
| 2024 | -$57.70M | +6.8% |
| 2023 | -$61.94M | -5.6% |
| 2022 | -$58.64M | -24.0% |
| 2021 | -$47.30M | -46.3% |
| 2020 | -$32.33M | -81.3% |
| 2019 | -$17.84M | -18.5% |
| 2018 | -$15.05M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$14.39M | -1.9% | +2.8% |
| June 30, 2025 | -$14.80M | +5.2% | -1.7% |
| March 31, 2025 | -$14.56M | -0.2% | -3.1% |
| September 30, 2024 | -$14.13M | +6.9% | +9.6% |
| June 30, 2024 | -$15.62M | +5.0% | -7.5% |
| March 31, 2024 | -$14.54M | +11.4% | +4.2% |
| September 30, 2023 | -$15.18M | -8.9% | +7.7% |
| June 30, 2023 | -$16.44M | -14.1% | -0.2% |
- Pulmonx Corp showed an increase of +7.0% in Operating Income compared to the prior fiscal year.
- Over the 2018–2025 period, Pulmonx Corp’s operating income has declined by 256.5% (from -$15.05 million to -$53.66 million).
- The most recent figure is from Pulmonx Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 10, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: